This statistic shows the cost for large cap biopharma companies to bring an asset to market from 2010 to 2020. According to the data, in 2020, the cost to bring an asset to market was almost 2.5 billion U.S. dollars.
Average cost to bring an asset to market for large biopharma companies from 2010 to 2020
(in billion U.S. dollars)
Characteristic
Cost in billion U.S. dollars
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Deloitte. (May 24, 2021). Average cost to bring an asset to market for large biopharma companies from 2010 to 2020 (in billion U.S. dollars) [Graph]. In Statista. Retrieved August 25, 2024, from https://www.statista.com/statistics/825698/cost-to-bring-large-cap-biopharmaceutical-assets-to-market/
Deloitte. "Average cost to bring an asset to market for large biopharma companies from 2010 to 2020 (in billion U.S. dollars)." Chart. May 24, 2021. Statista. Accessed August 25, 2024. https://www.statista.com/statistics/825698/cost-to-bring-large-cap-biopharmaceutical-assets-to-market/
Deloitte. (2021). Average cost to bring an asset to market for large biopharma companies from 2010 to 2020 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: August 25, 2024. https://www.statista.com/statistics/825698/cost-to-bring-large-cap-biopharmaceutical-assets-to-market/
Deloitte. "Average Cost to Bring An Asset to Market for Large Biopharma Companies from 2010 to 2020 (in Billion U.S. Dollars)." Statista, Statista Inc., 24 May 2021, https://www.statista.com/statistics/825698/cost-to-bring-large-cap-biopharmaceutical-assets-to-market/
Deloitte, Average cost to bring an asset to market for large biopharma companies from 2010 to 2020 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/825698/cost-to-bring-large-cap-biopharmaceutical-assets-to-market/ (last visited August 25, 2024)
Average cost to bring an asset to market for large biopharma companies from 2010 to 2020 (in billion U.S. dollars) [Graph], Deloitte, May 24, 2021. [Online]. Available: https://www.statista.com/statistics/825698/cost-to-bring-large-cap-biopharmaceutical-assets-to-market/